We are live on ! Find out more
ELC

Edgar Lomax Company Portfolio holdings

AUM $1.4B
1-Year Est. Return 20.67%
This Fund
S&P 500
This Quarter Est. Return
+12.38%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.6B
AUM Growth
+$133M
Cap. Flow
-$31.4M
Cap. Flow %
-1.96%
Top 10 Hldgs %
40.28%
Holding
82
New
18
Increased
15
Reduced
25
Closed
19

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$71.2M
2
MRK icon
Merck
MRK
+$45.2M
3
JNJ icon
Johnson & Johnson
JNJ
+$37.5M
4
UNH icon
UnitedHealth
UNH
+$36.2M
5
AMGN icon
Amgen
AMGN
+$35.6M

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$52.3M
2
RTX icon
RTX Corp
RTX
+$40.9M
3
BAC icon
Bank of America
BAC
+$38.4M
4
PFE icon
Pfizer
PFE
+$36M
5
HON icon
Honeywell
HON
+$32.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.18%
2 Financials 17.65%
3 Technology 10.34%
4 Industrials 9.95%
5 Consumer Staples 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
1
MetLife
MET
$62.5B
$90.1M 5.61%
1,481,501
-74,955
-5% -$4.14M
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
$73.6M 4.59%
1,340,830
-50,545
-4% -$2.5M
CVS icon
3
CVS Health
CVS
$134B
$73.5M 4.58%
+976,865
New +$71.2M
CSCO icon
4
Cisco
CSCO
$448B
$67M 4.18%
1,296,228
-334,245
-20% -$15.7M
CVX icon
5
Chevron
CVX
$383B
$66.4M 4.14%
633,272
+18,405
+3% +$1.8M
ALL icon
6
Allstate
ALL
$68.3B
$65.1M 4.06%
566,458
-152,795
-21% -$16.8M
XOM icon
7
ExxonMobil
XOM
$651B
$62.9M 3.92%
1,125,742
-45,065
-4% -$2.36M
VZ icon
8
Verizon
VZ
$193B
$54.5M 3.4%
937,456
+292,415
+45% +$16.5M
GD icon
9
General Dynamics
GD
$103B
$48M 2.99%
264,604
+75,265
+40% +$12.3M
MRK icon
10
Merck
MRK
$321B
$45.1M 2.81%
+612,535
New +$45.2M
KO icon
11
Coca-Cola
KO
$381B
$44.8M 2.79%
849,032
-88,755
-9% -$4.47M
T icon
12
AT&T
T
$159B
$43.4M 2.7%
1,896,605
-579,713
-23% -$12.8M
EXC icon
13
Exelon
EXC
$46.6B
$40.8M 2.54%
1,307,661
-936,059
-42% -$28.1M
UNP icon
14
Union Pacific
UNP
$172B
$40.4M 2.52%
183,450
+53,945
+42% +$11.3M
UNH icon
15
UnitedHealth
UNH
$383B
$38.9M 2.42%
+104,520
New +$36.2M
JNJ icon
16
Johnson & Johnson
JNJ
$617B
$38.1M 2.38%
+231,850
New +$37.5M
MMM icon
17
3M
MMM
$90.8B
$37.9M 2.36%
234,978
+40,389
+21% +$6.05M
AMGN icon
18
Amgen
AMGN
$209B
$37.1M 2.31%
+149,170
New +$35.6M
IBM icon
19
IBM
IBM
$209B
$36.3M 2.26%
284,776
-24,539
-8% -$2.94M
PG icon
20
Procter & Gamble
PG
$335B
$31.4M 1.96%
+232,115
New +$30.3M
ABBV icon
21
AbbVie
ABBV
$455B
$31.4M 1.96%
290,433
+166,690
+135% +$17.8M
WMT icon
22
Walmart Inc
WMT
$884B
$30.5M 1.9%
+672,945
New +$31.2M
PFE icon
23
Pfizer
PFE
$142B
$29M 1.81%
801,605
-1,013,555
-56% -$36M
GS icon
24
Goldman Sachs
GS
$302B
$28M 1.75%
85,665
-32,740
-28% -$10.2M
HD icon
25
Home Depot
HD
$332B
$25.9M 1.62%
+84,905
New +$23.4M

Similar funds

Edgar Lomax Company's Q1 2021 Portfolio in Review

As of Q1 2021, Edgar Lomax Company held 82 positions worth $1.6B, up 9% from $1.47B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Edgar Lomax Company's Q1 2021 filing shows 18 new, 15 increased, 25 reduced and 19 closed positions. Its largest new stake was CVS Health: 976,865 shares worth $73.5M. The largest sale was Capital One, an estimated $52.3M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 11% a quarter earlier, followed by Financials and Technology.

  • Edgar Lomax Company's largest Q1 2021 buy was CVS Health: 976,865 shares worth $73.5M.
  • Edgar Lomax Company added most to AbbVie in Q1 2021, an estimated $17.8M increase.
  • Edgar Lomax Company's biggest Q1 2021 reduction was Capital One, cutting an estimated $52.3M.
  • Edgar Lomax Company fully exited RTX Corp in Q1 2021, selling an estimated $40.9M.
  • Edgar Lomax Company's ten largest holdings make up 40% of its $1.6B portfolio in Q1 2021.
  • Edgar Lomax Company opened 18 new positions and closed 19 in Q1 2021.
  • Edgar Lomax Company's portfolio value rose 9% quarter-over-quarter to $1.6B.

Based on Edgar Lomax Company's 13F filing for Q1 2021, filed 14 May 2021.